LITTLE FALLS, N.J., Aug. 23, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that it has completed its previously announced acquisition of BHT Hygienetechnik Holding GmbH ("BHT Group"), the German market leader in automated endoscope reprocessing and related equipment and services as well as flexible endoscope repair.
About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.
For further information, visit the Cantel website at www.cantelmedical.com.
About BHT Group
BHT Group is the parent company of BHT Hygienetechnik GmbH and ESCAD Medical GmbH. BHT Hygienetechnik is the leading German manufacturer of automated endoscope reprocessors and instrument washer disinfectors and related service and accessories. ESCAD Medical specializes in high-quality endoscope storage and drying solutions as well as flexible endoscope repair services. For more information, please visit https://bht.de/en and http://www.escad-medical.com/en/start/.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE Cantel Medical Corp.
© 2017 PR Newswire. All Rights Reserved.